England to Limit Gatherings; Vaccine Safety Pledge: Virus Update
This article is for subscribers only.
Frontrunners in the race for a Covid-19 vaccine pledged to avoid shortcuts on science as they face pressure to rush a shot to market. AstraZeneca Plc put its Phase 3 study on hold after a suspected adverse reaction, STAT reported.
Europe’s fears of a virus resurgence are becoming reality with France’s health minister calling the surge in infections “worrisome.” Prime Minister Boris Johnson is poised to announce bans on social gatherings of more than six people in England.